Betaine Supplementation Attenuates S-Adenosylhomocysteine Hydrolase-Deficiency-Accelerated Atherosclerosis in Apolipoprotein E-Deficient Mice
Overview
Authors
Affiliations
S-adenosylhomocysteine (SAH) is a risk factor of cardiovascular diseases and atherosclerosis. However, the causal association between SAH and atherosclerosis is still uncertain. In the present study, heterozygous SAH hydrolase (SAHH) knockout mice were bred with apolipoprotein E-deficient mice to produce ApoE/SAHH mice. At 8 weeks of age, these mice were fed on AIN-93G diets added with or without betaine (4 g betaine/100 g diet) for 8 weeks. Compared with ApoE/SAHH mice, SAHH deficiency caused an accumulation of plasma SAH concentration and a decrease in S-adenosylmethionine (SAM)/SAH ratio as well as plasma homocysteine levels. Betaine supplementation lowered SAH levels and increased SAM/SAH ratio and homocysteine levels in ApoE/SAHH mice. Furthermore, SAHH deficiency promoted the development of atherosclerosis, which was reduced by betaine supplementation. The atheroprotective effects of betaine on SAHH-deficiency-promoted atherosclerosis were associated with inhibition of NFκB inflammation signaling pathway and inhibition of proliferation and migration of smooth muscle cells. In conclusion, our results suggest that betaine supplementation lowered plasma SAH levels and protected against SAHH-deficiency-promoted atherosclerosis through repressing inflammation and proliferation and migration of smooth muscle cells.
Wang X, Shao Y, Yang Z, Yang H, Wang Z Animals (Basel). 2025; 15(5).
PMID: 40076002 PMC: 11899362. DOI: 10.3390/ani15050719.
Wang H, Liu L, He X, Bian G J Poult Sci. 2025; 62:2025010.
PMID: 40060329 PMC: 11879611. DOI: 10.2141/jpsa.2025010.
Catalpol inhibits HHcy-induced EndMT in endothelial cells by modulating ROS/NF-κB signaling.
Wu C, Li Y, Liu S, Wang L, Wang X BMC Cardiovasc Disord. 2024; 24(1):431.
PMID: 39148029 PMC: 11328392. DOI: 10.1186/s12872-024-04046-z.
Mokry M, Boltjes A, Slenders L, Bel-Bordes G, Cui K, Brouwer E Nat Cardiovasc Res. 2023; 1(12):1140-1155.
PMID: 37920851 PMC: 10621615. DOI: 10.1038/s44161-022-00171-0.
Alkaissi H, McFarlane S Cureus. 2023; 15(7):e42259.
PMID: 37605676 PMC: 10440097. DOI: 10.7759/cureus.42259.